The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and ...

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...

AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.

This is to inform you that AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control ...

The approved indication involves using durvalumab in combination with chemotherapy as a neoadjuvant treatment, followed by ...

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

This approval allows Durvalumab to be used together with chemotherapy before surgery, and then as a single treatment ...

The company has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution ...

Astrazeneca Pharma India has received CDSO's (Central Drugs Standard Control Organisation) nod for the import of Durvalumab ...

Astrazeneca Pharma India Ltd registered volume of 10.98 lakh shares by 14:14 IST on NSE, a 166.41 fold spurt over two-week average daily volume of 6599 shares ...

Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 ...